Access cutting-edge chronic inflammatory demyelinating polyneuropathy treatment through this clinical trial at a research site in Homewood. Study-provided care at no cost to qualified participants.
Access chronic inflammatory demyelinating polyneuropathy specialists in Homewood at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic inflammatory demyelinating polyneuropathy treatment provided free
The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.
Sponsor: Sanofi
Check if you qualify for this chronic inflammatory demyelinating polyneuropathy clinical trial in Homewood, AL
If you're searching for chronic inflammatory demyelinating polyneuropathy treatment options in Homewood, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Homewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.